N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.

Details

Language :

English

ISSN :

15228517

Volume :

21

Issue :

1

Database :

Complementary Index

Journal :

Neuro-Oncology

Publication Type :

Academic Journal

Accession number :

133717767

Full Text :

https://doi.org/10.1093/neuonc/noy161